Clinical Trial Update: Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease [Phase 1]

View source ↗

Summary

Phase 1 study completed to evaluate the pharmacokinetic interaction between lapatinib and JTZ-951 in subjects with end-stage renal disease due to anemia of chro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• JTZ-951
• Lapatinib (Lapatinib)

Snippet

Sponsor: Akros Pharma Inc. | Conditions: Anemia of Chronic Kidney Disease | Phase 1 | Status: COMPLETED